10 - 12 June, 2025
Congress CenterBasel Switzerland Daniëlle Krijgsman, PhDAssistant Professor at UMC UtrechtSpeaker
Profile
Daniëlle Krijgsman completed her PhD at Leiden University Medical Center (Netherlands) and Aarhus University (Denmark), focusing on tumor-immune interactions in colorectal cancer. Following a postdoc at UMC Utrecht on myeloid cells and therapy resistance, she now serves as an Assistant Professor at UMC Utrecht, developing novel myeloid/complement-targeting immunotherapies for cancer and leading the development of ARGX-117, an anti-C2 antibody for complement inhibition in neuroinflammatory diseases.
Agenda Sessions
From Bench to Bedside: The Journey of ARGX-117, An Anti-C2 Antibody to inhibit Complement Activation in Multifocal Motor Neuropathy
, 09:00View Session